Case Presentations.

Slides:



Advertisements
Similar presentations
Abuse or Dependence? Assessing the Alcoholic patient in the Clinic. Antoni Gual Alcohol Unit Psychiatry Department Neurosciences Institute.
Advertisements

Substance Related Disorders
Psychiatry interview History Taking
Judith Martin, MD Medical Director of Substance Use Services, SFDPH
Welcome to the Open Sky Webinar! We will start at 6pm- see you soon.
DSM – 5 Substance-Related and Addictive Disorders
Benzodiazepine dependence in primary care Aisha Bhaiyat 13 April 2010.
DSM 5 Opioid – Related Disorders Dr. Phil O’Dwyer Oakland University Brookfield Clinics January 24, 2014.
Facts In 2008, an estimated 20.1 million Americans aged 12 or older were current (past-month) illicit drug users. (8.0% of the population) million.
Practice Principles and Pharmacology CSD 5970 Counseling the Chemically Dependent.
Substance Abuse Screening and Assessment CSD 5970.
Medical Model of Addiction
Young people and the consequences of marijuana use Kevin Haggerty, Ph. D. Social Development Research Group, University.
Section 4.3 Depression and Suicide Slide 1 of 20.
©2010 McGraw-Hill Higher Education. All rights reserved. Chapter 4 Definitions of Substance Abuse, Dependence, and Addiction.
North Carolina TASC Clinical Series Training Module Eight: DSM -IV.
DOUGHNUTSDOUGHNUTS. Opioid Agonist Therapy The Skinny on Methadone et al.
Assessment of Substance Use Disorders
Concerns About Addiction: Bringing Clarity to Confusion about Addiction Terminology Aaron M. Gilson, MS, MSSW, PhD Research Program Manager/Senior Scientist.
For Pain or Not for Pain: Methadone Madness
Opiates in Chronic Pain Dr S Vas, Barnsley VTS October 2014.
FIVE MINUTES TO MAKE A DIFFERENCE Presentation by: Mark Barnes.
Opioid Use in Workers’ Compensation Suzanne Novak, MD, PhD November 2008.
Problem Behaviors Norman Wetterau. Less serious Ran of out pills three days early After one year lost pills Had a headache and a friend gave her a vicodin.
NICE guidance Generalised Anxiety Disorder Alex Hill.
Opioid Tapering Paul Coelho, MD David Tauben, MD Melissa Weimer, DO, MCR.
Opioids Tapering Melissa B. Weimer, DO, MCR. Disclosures Dr. Weimer is a consultant for INFORMed, IMPACT education, and the American Association of Addiction.
Primary Care Models for Chronic Pain Treatment Melissa Weimer, DO, MCR.
Denis G. Patterson, DO ECHO Project April 20, 2016 CDC Guidelines for Prescribing Opioids for Chronic Pain.
A System to Manage Long Term Opioid Prescribing in the Primary Care Setting Joy Nassar, MD University Medicine Foundation November 16, 2015.
December 10, 2015 Arthur Robin Williams MD MBE American Academy of Addiction Psychiatry Division on Substance Abuse Department of Psychiatry, Columbia.
Prepared by Dr. Ramin Safakish, MD, FRCPC – March 2016.
Effects of Sexual Abuse Across the Span. Child Who Are Sexually Abused Earlier onset of puberty Depression PTSD Increased rates of obesity Abuse alcohol.
Current Concepts in Pain Management
Chapter 14 Drugs Lesson 1 Drug Misuse and Abuse Next >>
Paul Coelho, MD Mark Sullivan, MD, PhD Melissa Weimer, DO, MCR
Cover slide.
Medi-cal covered inpt tx in SoCo?
Opioids Aware A resource for patients and healthcare professionals to support prescribing of opioid medicines for pain.
Drug and Alcohol Abuse By Dr Sarah Cochrane.
screening, brief intervention & referral to treatment
WHY A FOCUS ON ADDICTIVE BEHAVIORS?
Neonatal Abstinence Syndrome: An emerging issue for Part C systems?
Opioids Aware A resource for patients and HCPs to support prescribing of opioid medicines for pain Sue Mulvenna CDAO NHSE S SW March 2016.
oxycontin addiction treatment
STOP! Safe Treatment of Pain
Opioid Prescribing & Monitoring
DSM-IV-TR, APA, 2000 Criteria for Substance Dependence:
Complete a legally valid prescription.
Controlled substance compliance
Parent-Child Assistance Program (PCAP) 1991-present An intensive 3-year home visitation intervention for pregnant and parenting, alcohol/drug abusing.
Differentiating Drug-Seeking Behavior From Poorly Controlled Pain
Substance Use Disorders
Methadone Scenario 3 Based on Stigma & Trust Findings from the
Opioids in Butte County
Assessing Opioid Use Disorder, part 1
Prescription Drug Monitoring Program
An Interprofessional Perspective on the Safe and Appropriate Use of Opioid Analgesics.
Diagnosis and Recognition of OUD
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Prescription Drug Monitoring Program
What is suicide? Suicide is the act of intentionally causing one's own death. It is the 10th leading case of death in the United States and over 40,000.
Office of Aerospace. Medicine
Essentials of Good Pain Care: A Team-Based Approach
Case 1 – 17 yo white female 2 year history of using opioids – prescription post minor surgery, continued use post prescription (non-medical sources) –
Substance Abuse.
Pain Management JEFFREY TAN HO, D.O.
Bassett-UMass MAT ECHO.
Opiate misuse among our seniors
Acute Pain Management & Addiction
Presentation transcript:

Case Presentations

Case 1: Lymphoma in remission 23 yo patient with hx of depression, suicide attempts, and T lymphoblastic lymphoma in remission on maintenance treatment. She developed severe wide-spread joint pain during her treatment and was prescribed up to 10-12mg hydromorphone Q4 H PRN. She has been unable to taper her medication and frequently asks for early refills. She is also needing stimulant medication to help with profound fatigue. Her mother and her provider are worried about her. What do you do?

Case 1: Her pain treatment is transferred to Internal Medicine She is dissatisfied that she is now asked to do the following Opioid agreement Urine drug test 28 day refills After lengthy discussions, she complies with taper and considers buprenorphine as an alternative She continues to struggle with depression

Case 1: Opportunities Emphasize non-opioid pain management Focus on functional gains/progress Engage in mental health care Consider limiting opioid dose* Establish opioid risk assessment and explain risks Establish opioid agreements Carefully monitor prescription use 28 day prescriptions, eRx Consider urine drug tests Refer prior to problems developing

Use a Risk-Benefit Framework NOT… Is the patient good or bad? Does the patient deserve opioids? Should this patient be punished or rewarded? Should I trust the patient? Do the benefits of opioid treatment outweigh the untoward effects and risks for this patient (or society)? RATHER… In terms of a viable framework, this all makes sense if we always think about issues around opioids as health-related issues. So, it’s not is the patient good or bad, or does the patient deserve to have opioids, whether we should reward them if they behave well and punish them if they might be aiming towards misuse. We need to frame this instead as a risk/benefit assessment for an individual patient. So, if a patient has a history of substance misuse or mental health disorders that may make them more at risk, we are implementing these strategies in order to keep them safe. And when issues arise, we need to think of what might be driving them in terms of the patient’s health. So, these strategies are for the benefit of the individual patient and for the benefit of society or the public health. Judge the opioid treatment – NOT the patient Nicolaidis C. Pain Med. 2011 Jun;12(6):890-7.

Case 35 yo female with chronic daily migraine and diffuse myofascial pain who has been prescribed opioids for 5 years after the birth of her daughter. The patient has severe depression and anxiety, chronic nausea, history of adverse childhood experience (neglect as a child), and obesity. She is a stay at home mother to her 2 children, but frequently has to put the children in daycare because she can not care for them when she has severe migraines. She is also prescribed chronic high dose benzodiazepines by a psychiatrist. The patient has a history of losing her opioid prescription, obtaining opioids from another provider, being allergic to most other pain medication options, missing appointments, and frequently asking for opioid dose increases.

Case: Thought Questions Does this patient have pain? Does this patient have an opioid use disorder? What factors place this patient at risk for an opioid use disorder? What can you do to help this patient?

DSM-V criteria Unable to fulfill major role obligations Social or interpersonal problems due to use Use in hazardous situations Tolerance* Withdrawal/physical dependence* Taken in larger amounts or over longer period than wanted Unsuccessful efforts to cut down or control use Great deal of time spent to obtain substance Important activities given up or reduced Continued use despite harm (physical and psychological) Craving *If opioids are prescribed and taken as prescribed, these criterion do not apply.